Filing metadata

Accession number
0000899243-21-019515
Form type
Form 4
Filer
Oyster Point Pharma, Inc.
CIK
CIK 1720725
Filed
May 14, 2021
Reporting period
May 12, 2021
Description
Insider transaction

Explore SEC Filings Hub